SALVAGE Trial (Safety And cLinical Value of AutoloGous rEinfusion)
NCT: NCT07712666 · NOT_YET_RECRUITING
広告
NCT識別子NCT07712666
ステータスNOT_YET_RECRUITING
開始日2026-11-01
完了2029-08-01
SponsorMayo Clinic (OTHER)
First posted
Last updated
概要
The investigator hypothesizes intraoperative salvaged red blood cells are a poor substitute for allogenic packed red blood cell transfusions. In addition to providing inadequate resuscitation, salvaged red blood cells can increase the rate of complications, including postoperative electrolyte abnormalities, thrombocytopenia, anemia, and coagulopathy.
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。